NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

Jondo, while true that the industry theaters are not part of the scientific session, they are not a free for all. ASCO must approve the content and the content must comply with regulations. Last time they used this pathway they were not amidst a regulatory process. This time they are. The rules get enforced once you get to that stage.

7. Theater Participants shall submit speakers and topics to ASCO for approval prior to being publicized.
8. Theater activities shall not include information, papers, or abstracts that have not yet been presented at the Annual Meeting or other ASCO Meetings. This bit means you can’t preview material before it gets presented at the meeting. All Theater sessions shall comply with ASCO’s Abstract Confidentiality Policy.
9. Theater Participants and all activities in the Theater must comply with all applicable laws and guidance, including U.S. Food and Drug Administration (FDA) laws, regulations, and guidelines, including those regarding industry-supported scientific and educational activities; the Council of Medical Specialty Societies (CMSS) Code for Interactions with Companies; the American Medical Association (AMA) Ethical Opinion on Gifts to Physicians; the PhRMA Code on Interactions with Healthcare Professionals; the Office of Inspector General Compliance Program Guidance for Pharmaceutical Manufacturers; and all intellectual property laws and legal requirements.

One of our resident attorneys posted the premarket promotion regulation.

https://www.asco.org/sites/new-www.asco.org/files/content-files/meetings/documents/2022-AM-Industry-Expert-Theater-Guidelines.pdf